Thrush and Fever as Markers of Immune Competence in the Era of Highly Active Antiretroviral Therapy
- 15 September 2001
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 17 (14) , 1311-1316
Abstract
The presence of clinical manifestations of HIV-1 infection is one measure of immune function failure. We examined the occurrence of clinical manifestations of HIV-1 infection, in particular fever and oral thrush, before and after the initiation of highly active antiretroviral therapy (HAART). Using data collected from 645 participants in the Multicenter AIDS Cohort Study (MACS) who used HAART, 7517 person-visits from January 1992 through March 2000 were stratified by time relative to HAART initiation (≥1 year preinitiation, 1 year postinitiation, and ≥1 year postinitiation) and CD4+ T cell count (≤100, 101-200, 201-350, and >350 cells/μl). Multivariate logistic regression was used to assess the relationship between HAART, CD4+ T cell count, and each self-reported symptom (oral hairy leukoplakia, diarrhea, fever, and oral thrush). After initiation of HAART, clinical manifestations of HIV-1 infection continued to occur and, similar to patterns seen before HAART, were more likely at lower CD4+ T cell counts than at higher (p < 0.001). Except for diarrhea, symptoms did not occur more frequently after HAART. Rather, beyond 1 year after initiation of HAART, there was less oral thrush even at the same CD4+ T cell count. These results provide evidence that increases in CD4+ T cell count due to HAART represent a reconstitution of immune function.Keywords
This publication has 27 references indexed in Scilit:
- Increase and Plateau of CD4 T-Cell Counts in the 3½ Years After Initiation of Potent Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Natural History of Human Immunodeficiency Virus Type 1 Viremia after Seroconversion and Proximal to AIDS in a Large Cohort of Homosexual MenThe Journal of Infectious Diseases, 2000
- Reversal of Human Immunodeficiency Virus Type 1-Associated Hematosuppression by Effective Antiretroviral TherapyClinical Infectious Diseases, 2000
- Comparison of Clinical Manifestations of HIV Infection Among Women by Risk Group, CD4+ Cell Count, and HIV-1 Plasma Viral LoadJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapyAIDS, 1999
- Decreased Medical Expenditures for Care of HIV-Seropositive PatientsPharmacoEconomics, 1999
- Quality control in the flow cytometric measurement of T-lymphocyte subsets: The Multicenter AIDS Cohort Study experienceClinical Immunology and Immunopathology, 1990
- THE MULTICENTER AIDS COHORT STUDY: RATIONALE, ORGANIZATION, AND SELECTED CHARACTERISTICS OF THE PARTICIPANTSAmerican Journal of Epidemiology, 1987
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- Oral Candidiasis in High-Risk Patients as the Initial Manifestation of the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1984